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Abstract
Introduction: It is hypothesized that administration of stromal/stem cells isolated from the adipose tissue (ASCs)
and umbilical cord (HUCPVCs) can ameliorate the injured central nervous system (CNS). It is still not clear, however,
whether they have similar or opposite effects on primary cultures of neuronal populations. The objective of the
present work was to determine if ASCs and HUCPVCs preferentially act, or not, on specific cell populations within
the CNS.
Methods: Primary cultures of hippocampal neurons were exposed to ASCs and HUCPVCs conditioned media (CM)
(obtained 24, 48, 72 and 96 hours after three days of culture) for one week.
Results: Cell viability experiments (MTS (3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4-sulfophenyl)-
2H tetrazolium) test) revealed that CM obtained from both cell populations at all time points did not cause any
deleterious effects on neuronal cells. In fact, it was determined that whenever the ASCs CM were supplemented
with basic fibroblast growth factor (bFGF) and B27, there was a significant increase in the metabolic viability and
neuronal cell density of the cultures. On the other hand, in the absence of CM supplementation, it was the
HUCPVCs secretome that had the highest impact on the metabolic viability and cell density. In an attempt to
unveil which factors could be involved in the observed effects, a screening for the presence of bFGF, nerve growth
factor (NGF), stem cell factor (SCF), hepatocyte growth factors (HGF) and vascular endothelial growth factor (VEGF)
in the CM was performed. Results revealed the presence of all these factors in ASCs CM, except bFGF; in contrast,
in HUCPVCs CM it was only possible to detect robust NGF expression.
Conclusions: Overall, the results confirm important differences on the secretome of ASCs and HUCPVCs, which
lead to distinct effects on the metabolic viability and neuronal cell densities in primary cultures of hippocampal
neurons; however, the factor(s) that promote the stronger effect of the HUCPVCs CM in neuronal survival is(are) still
to be identified.
Introduction
Currently there are no effective treatments for major cen-
tral nervous system (CNS) injuries/disorders [1]. In the
last decade, stem/progenitor cells isolated from the adi-
pose tissue (ASCs) and the Wharton jelly of the umbilical
cord have been proposed for possible transplantation as a
therapy for CNS injuries [2-4]. Presently, it is commonly
accepted that their potency is related mainly to their
secretome, that is, to the production of molecules with a
neuroregulatory character that support neuronal/glial cell
survival and create an environment conducive to regen-
eration by endogenous cells [2,3].
Salgado et al. [5] demonstrated that the conditioned
media (CM) of a population of mesenchymal progenitors
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isolated from the Wharton jelly, located in the perivascu-
lar region of the umbilical cord (human umbilical cord
perivascular cells - HUCPVCs), were able to increase cell
viability, survival and proliferation in primary cultures of
hippocampal neurons and glial cells. Koh et al. [6] also
revealed that the expression of granulocyte colony-stimu-
lating factor (G-CSF), vascular endothelial growth factor
(VEGF), glial derived neurotrophic factor (GDNF) and
brain derived neurotrophic factor (BDNF) could be cor-
related with the neuroprotector effect revealed by stem
cells isolated from the bulk of the Wharton jelly (WJ-
MSCs), when transplanted to animal models of brain
ischemia. Similar findings were also reported by Ding et
al. [7] in an animal model of ischemic stroke. In this case
the transplantation of human WJ-MSCs was not only
able to promote functional recovery of behavioral deficits,
but also the reduction of the lesion size, a higher extent
of vascularization in ischemic areas and finally a higher
expression of Stem Cell Derived Factor 1 (SDF-1), BDNF
and GDNF in ischemic tissues. Identical outcomes were
also observed in other animal models of injury within the
CNS. For instance, Yang and colleagues [8] reported the
improvement of spinal cord injured rats upon transplan-
tation of undifferentiated WJ-MSCs and related these
results with the expression of human neutrophil-activat-
ing protein-2 (NAP-2), neurotrophin-3 (NT-3), basic
fibroblast growth factor (bFGF), glucocorticoid induced
tumor necrosis factor receptor (GITR) and vascular
endothelial growth factor receptor 3 (VEGFR-3). Finally,
Weiss et al. [9] also revealed that WJ-MSCs could induce
an overall improvement in the condition of an animal
model of Parkinson’s Disease (PD) through an increase of
expression of GDNF at the site of injury.
Similar to what has been reported for stem cells isolated
from the WJ’s UC, growth factors such as VEGF, hepato-
cyte growth factor (HGF), bFGF, insulin like growth factor
(IGF-1) and others have also been found in the ASCs
secretome [10-12].
The ASCs application in models of injury, neurodegen-
eration and neurotoxicity is also well described. For
instance Lee et al. [13] showed that ASCs transplantation
into a mice model of Huntington Disease (HD) slowed
down the disease progression by modulating the host
pathogenesis. Lu and colleagues [14] also revealed that
ASCs secretome exerted neuroprotection on glutamate
mediated excitotoxicity in a PC12 cell line model. More-
over, this was partially related to the presence of different
levels of BDNF, VEGF and HGF [15]. Another study using
the PC12 cell line also reported interesting results [14]. In
this particular work it was observed that ASCs conditioned
media was able to induce cell neuritogenesis, and that this
effect was partially mediated through a NGF related
mechanism. Finally, ASCs application to a rat model of
brain hypoxic-ischemic injury was also reported by Wei
et al. [16]. Their objective was to study the role of concen-
trated conditioned media from cultured rat ASCs (ASC-
CM) on the protection/recovery of the model. Both beha-
vioral analysis and post-mortem evaluation of brain
damage revealed that the conditioned media had a neuro-
protective character. In this case IGF-1 and BDNF were
indicated as the main mediators of the observed effects.
As it was shown, the effects of these cells on different
CNS cell populations are relatively well described. How-
ever, a direct comparison of the effects of their secretome
on CNS cells has not been performed. Therefore, the
objective of the present work was to determine and com-
pare the effects of the secretome of human ASCs and
HUCPVCs on primary cultures of post-natal rat hippo-
campal neurons. For this purpose the latter were incu-
bated with either conditioned media (CM) from ASCs or
HUCPVCs. Results revealed that both ASCs and
HUCPVCs secretome are able, in distinct forms, to
increase cell viability and cell densities in the tested cul-
ture system, a fact that can be considered as an indicator
of significant differences in their secretome composition.
Methods
Cell culture
Adipose tissue derived stem cells
ASCs were isolated according to a protocol previously
described by Dubois et al. [17]. All protocols were
reviewed and approved by the Pennington Biomedical
Research Center Institutional Research Boards (IRB) prior
to the study. Liposuction aspirates from subcutaneous adi-
pose tissue sites (abdomen, flank, thighs) were obtained
from female subjects undergoing elective plastic surgical
procedures. All donors gave their written informed con-
sent. Tissues were then digested in a 0.1% collagenase type
I solution (Worthington Biochemical Corporation, Lake-
wood, NJ, USA) pre-warmed to 37°C for 60 minutes, after
which they were centrifuged for five minutes at 300 g to
500 g at room temperature. The supernatant, containing
mature adipocytes, was aspirated. The pellet was identified
as the stromal vascular fraction (SVF). The SVF was resus-
pended and plated immediately in T225 flasks in Stromal
Medium [DMEM/F 12 Ham’s, 10% fetal bovine serum
(Hyclone, Logan, UT, USA), 100 U penicillin/100 μg strep-
tomycin/0.25 μg Fungizone ] at a density of 0.156 ml of
tissue digest/cm2 of surface area for expansion and cul-
ture. After reaching confluence, cells were passaged and
kept in stromal medium.
Human umbilical cord perivascular cells
HUCPVCs were isolated from the UCs of local consenting
full-term caesarean section patients. Ethical approval had
been previously obtained from Hospital de S. Marcos,
Braga, Portugal. Parents gave their written informed con-
sent prior to the umbilical cord collection. Cells were iso-
lated according to the procedure originally described by
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Sarugaser et al. [18]. Pieces of cord, 4 to 5 cm long, were
dissected by first removing the epithelium of the UC sec-
tion along its length to expose the underlying WJ. Each
vessel, with its surrounding WJ matrix, was then pulled
away and incubated in a 0.5 to 0.75 mg/ml collagenase
(Sigma, St. Louis, MO, USA) with PBS (Gibco, Grand
Island, NY, USA) solution for 18 hours. Supernatant was
then diluted with PBS to reduce the viscosity of the sus-
pension and centrifuged. Cells were further resuspended
in culture media [a-MEM (Gibco) supplemented with
10% FBS (Gibco) and 1% antibiotic/antimycotic (Sigma)],
plated in T75 flasks at a density of 4,000 cells/cm2. The
culture medium was changed every two to three days.
Upon confluence cells were trypsinized and passaged to
new T75 flasks.
Hippocampal neurons
Hippocampal neuronal cultures were prepared from P4
Wistar rats [4]. Briefly, upon dissection, hippocampi were
submitted to a trypsin based enzymatic digestion followed
by mechanical dissociation. Isolated cells were then plated
on Poly-D-Lysine (Sigma) coated coverslips at a density of
4,000 cells/cm2. Cultures were then incubated with CM
and respective controls, as described in 2.2.
Conditioned medium collection and experiments
CM was collected from P5 ASCs and HUCPVCs. For this
purpose cells were plated out at a density of 4,000 cells/
cm2 and allowed to grow for three days. On day three, cul-
ture medium was renewed and CM were collected 24, 48,
72 and 96 hours thereafter and frozen. For CM collection
Neurobasal-A medium supplemented with kanamycin
(Gibco, 0.1 to mg/ml) was the chosen medium. Upon iso-
lation, hippocampal neurons were plated out at the densi-
ties referred above and incubated from T0 with the
previously collected and filtered CM (n = 3/CM time
point) for seven days, after which cell viability and differ-
entiation were assessed (see below). Two experimental set-
ups were outlined: 1) B27 (Gibco) supplement and bFGF
(Gibco, 10 ng/ml) were added to the CM prior to neuron
incubation (control: standard Neurobasal-A media supple-
mented with the same concentrations of bFGF, B27 and
kanamycin) and 2) CM were used as taken from the cul-
tures flasks, without the addition of the supplements
referred in 1).
Cell viability assessment
Cell viability was assessed by the MTS test. The MTS (3-
(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-
2(4-sulfophenyl)-2H tetrazolium) (Promega, Madison,
WI, USA) test is an assay in which the substrate, MTS, is
bioreduced into a brown formazan product by nicotina-
mide adenine dinucleotide phosphate (NADPH) or
NADP produced by mitochondrial enzymes, which are
active in living cells. Cell culture coverslips (n = 3) were
placed in culture medium containing MTS in a 5:1 ratio
and incubated in a humidified atmosphere at 37ºC and
5% CO2. After three hours of incubation, 100 μl of solu-
tion from each sample was transferred to 96 well plates
and the optical density was determined at 490 nm.
Results are shown as a ratio between CM and control
incubated cultures.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde for 30 minutes,
permeabilized by incubation with 0.3% Triton X-100 in
PBS for five minutes at room temperature (for neurons
and astrocytes), and washed three times in PBS. Cells were
then blocked with 10% FBS/PBS (60 minutes), followed by
a 60-minute incubation with a mouse anti-rat microtubule
associated protein 2 (MAP-2) (Sigma) antibody in order to
detect mature hippocampal neurons. Cells were then
washed in PBS and incubated with Alexa Fluor 594 goat
anti-mouse immunoglobulin G (IgG). Primary antibody
was omitted to produce negative controls. Samples were
observed under an Olympus BX-61 Fluorescence Micro-
scope (Olympus, Germany).
Cell counts
Cell counts were performed by using Cell-P software
(Olympus, Germany). For this purpose three cover slips
per condition and three representative fields were chosen
and analyzed. Results are shown as a ratio between the
percentage of MAP-2 positive cells found in CM and con-
trol incubated cultures, respectively.
Analysis of the conditioned media of ASCs and HUCPVCs
CM were assayed for cytokines using a Bio-plex human 5-
plex panel immunoassay kit (Bio-Rad, Hercules, CA,
USA), according to the manufacturer’s instructions. The
5-plex panel consisted of the following analytes: bFGF,
VEGF, NGF, SCF and HGF. A standard range of 0.2 to
3,200 pg/mL was used. CM samples were collected as pre-
viously described, centrifuged and frozen. Samples and
controls were run in triplicate, standards and blanks in
duplicate. Results were normalized to the total protein
present in the respective CM.
Statistical analysis
Statistical evaluation was performed using one way (hip-
pocampal neurons experiments) analysis of variance
(ANOVA) tests to assess the statistical differences. Statis-
tical significance was defined as P < 0.05.
Results and discussion
The present study set out to determine to what extent
the secretome of two populations of human stromal/
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stem cells, ASCs and HUCPVCs, influence the viability
and cellular densities of rat post-natal hippocampal
neurons.
Figures 1 and 2 show the results obtained when hippo-
campal cultures were incubated for seven days with CM
separately collected from ASCs or HUCPVCs. As it can
be observed, none of the conditions used led to an overall
decrease of cell metabolic viability among the primary
hippocampal cultures in both supplemented and non-
supplemented conditions (Figure 1). In supplemented
CM the metabolic viability/activity of the neuronal cells
was clearly upregulated in ASC CM (P < 0.05 for control
and CM 24-72 h), even when compared to the results
obtained for HUCPVCs CM. After this first and more
general approach, an immunocytochemistry was per-
formed for MAP-2 positive cells. This was performed, as
the referred neuronal culture system is not 100% pure,
presenting also astrocytes, neural progenitor and
endothelial cells. The immunocytochemical analysis
revealed that hippocampal cultures incubated with both
ASCs and HUCPVCs supplemented CM had increased
MAP-2 positive cell (neurons) densities when compared
to control cultures. Still regarding this parameter, it
was also possible to observe that for the 96-hour CM
there were significant differences between ASCs and
HUCPVCs CM (P < 0.05). Moreover, consistent with the
MTS test, the secretome of the two stem cell populations
displayed different temporal profiles. While cultures
incubated with ASCs CM present similar values for
MAP-2 positive cells throughout time (24-96 h),
HUCPVCs CM presented a decaying temporal profile
(Figure 1). However, when the conditions were changed
and neuronal cells received the CM secretome alone
(Figure 1), without the supplementation of bFGF and
B27, the viability/metabolic assays results changed sub-
stantially. Under these conditions, the HUCPVCs CM-
Figure 1 Cell metabolic viability (MTS test) and cell densities, for MAP-2 positive cells, after incubation with ASCs and HUCPVCs
supplemented and non-supplemented conditioned media (CM). Results for metabolic viability revealed that the action of ASCs CM was
potentiated by the addition of exogenous bFGF and B27, leading to drastic increases in cell metabolic viability. On the other hand HUCPVCs CM
did not need the addition of exogenous factors to induce similar effects in primary cultures of hippocampus. (Results shown as a ratio between
CM and Control (Ct) n = 3 ± SD, one way ANOVA, P < 0.05). ANOVA, analysis of variance; ASCs, adipose tissue derived stem cells; bFGF, basic
fibroblast growth factor; HUCPVCs, human umbilical cord perivascular cells; MTS, (4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2(4-
sulfophenyl)-2H tetrazolium; SD, standard deviation.
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incubated cultures showed a clear up-regulation of the
metabolic viability when compared to control and ASCs
CM cultures (P < 0.05). Still, ASCs CM-incubated cul-
tures also had a significant increase when compared to
controls, but this was marginal when compared to that
obtained with HUCPVCs CM. The determination of cell
densities disclosed a similar trend (Figures 1 and 2).
Overall, there was a decrease in the densities of MAP-2
positive cells for cultures incubated with non-supplemen-
ted CM, when compared with the supplemented CM
conditions. The HUCPVCs secretome induced a clear
positive response for the 24 h time point. There was a
tendency to decay with time, as the HUCPVC 96-h CM
values were slightly decreased when compared to those
obtained for ASCs CM. These results, namely, the tem-
poral profile disclosed by the HUCPVCs secretome are of
note, as they are different from those reported by Salgado
et al. [5] using P2 HUCPVCs. In that report HUCPVCs
CM did not present a temporal profile regarding MAP-2
cell densities, a fact that may indicate that the secretome
of these cells could be changing with the serial passaging
of the cells.
In an attempt to determine which factors were being
expressed by these cells, an antibody-based multianalyte
Bio-Plex platform analysis (using the xMAP technology
by Luminex™) for bFGF, NGF, SCF, HGF and VEGF,
was conducted (Table 1). These growth factors were
selected as they have been previously implicated in neuro-
nal survival and differentiation [1,2]. It was possible to
detect important variations between ASCs and
HUCPVCs CM regarding the presence of these factors.
While ASCs CM was positive for the presence of VEGF,
NGF, SCF and HGF, HUCPVCs CM only revealed the
presence of NGF and VEGF (and the latter just for one
time point of collection). Thus, in a comparison between
these two CM it becomes obvious that NGF is the only
Figure 2 Fluorescence microscopy micrographs of primary cultures of hippocampal neurons stained for the neuronal marker MAP-2,
incubated under control conditions (A, C) and with ASCs supplemented CM (B) and non-supplemented HUCPVCs CM (D). As it can be
observed both CM incubated cultures disclosed higher densities of MAP-2 positive cells, when compared to controls. ASCs, adipose tissue
derived stem cells; CM, conditioned media; HUCPVCs, human umbilical cord perivascular cells; MAP-2, microtubule associated protein 2.
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common factor present in similar amounts; moreover,
both CM did not reveal the presence of bFGF. While the
absence of bFGF in the ASCs CM seems to preclude the
beneficial effects of this CM in neuronal survival and den-
sities, it did not affect the actions of the HUCPVCs CM
that might be promoted by NGF. However, these results
also suggest that the differential effects of ASCs and
HUCPVCs CM should not be attributed to any of these
factors, as the HUCPVCs CM produced better results for
cell survival and differentiation under no supplemented
conditions, but rather to the presence of other, still uni-
dentified, factors. Therefore, future work should be
focused on the identification of such factors using more
potent techniques such as those suggested by Zvonic [19]
and She [20]. Additionally, it is also important to deter-
mine whether these differences would be maintained, if
the CM used in the present report were injected into the
rat hippocampus. Finally, it will also be important to
compare the secretome of the cells under study, and its
effects, to those of MSCs isolated from other sources,
namely, bone marrow and embryonic stem cells [21-24].
Conclusions
The present work demonstrates that ASCs and HUCPVCs
release trophic/neuroregulatory factors that improve the
metabolic viability of hippocampal cultures. Importantly, it
was possible to observe that their secretome acts differ-
ently on the cell viability and densities of post-natal cul-
tures of hippocampal neurons. ASCs secretome effects are
dependent on the interaction with added exogenous fac-
tors such as bFGF, while, on the other hand, HUCPVCs
secretome is able to promote neuronal survival/differentia-
tion in the absence of exogenous supplements.
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